Furthermore, the initiation of SGLT2 inhibitors was shown to induce a short-term elevated natriuresis followed by a compensatory increase in sodium reuptake through tubular transporters and transient systemic activation of the RAAS in patients with T2DM (32). The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.